Ebru Akkemik

Ebru Akkemik

Auto-generated profile, based on publicly available information

Ebru Akkemik

Siirt University

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2012 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
EAEbru Akkemik
Ebru Akkemik
PTPinar Taser
Pinar Taser
ABAysegul Bayindir
Aysegul Bayindir
HBHarun Budak
Harun Budak
MCMehmet Ciftci
Mehmet Ciftci

17 March 2010 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
EAEbru Akkemik
Ebru Akkemik
HBHarun Budak
Harun Budak
MCMehmet Ciftci
Mehmet Ciftci
The inhibitory effects of some drugs on 6-phosphogluconate dehydrogenase from human erythrocytes have been investigated. For this purpose, initially, erythrocyte 6-phosphogluconate dehydrogenase was purified 3364 times in a yield of 58% by using ammonium sulfate precipitation and 2′,5′-ADP Sepharose 4B affinity gel. A temperature of +4°C was maintained during the purification process. Enzyme activity was determined with the Beutler method by using a spectrophotometer at 340 nm. This method was utilized for all kinetic studies. Many commonly used drugs were investigated in this study. Some drugs (ketotifen (Ki: 8.3 ± 1.7 μM), dacarbazine (Ki: 10.1 ± 0.7 μM), meloxicam (Ki: 50.9 ± 13.2 μM), furosemide (Ki: 127 ± 37.8 μM), methotrexate (Ki: 136.7 ± 25.3 μM), metochloropramide hydrochloride (Ki: 2.1113 ± 0.6979 mM), ritodrine hydrochloride (Ki: 6.0353 ± 1.2783 mM), and gadopentetic acid (Ki: 73.4 ± 21.9 mM)) inhibited enzyme activity in vitro. Ki constants for the enzyme were found by means of Lineweaver–Burk graphs. All drugs showed non-competitive inhibition. In addition, IC50 values of the drugs were determined by plotting activity percent vs [I].

30 January 2013 in Toxicology and Industrial Health
Verified
Journal Article
Closed access
VCVeysel Comakli
Veysel Comakli
EAEbru Akkemik
Ebru Akkemik
MCMehmet Ciftci
Mehmet Ciftci
OKOmer Irfan Kufrevioglu
Omer Irfan Kufrevioglu
Glucose 6-phosphate dehydrogenase (d-glucose 6-phosphate: NADP+ oxidoreductase, EC 1.1.1.49; G6PD) is a key enzyme that is localized in all mammal tissues, especially in cytoplasmic sections and that catalyzes the first step of pentose phosphate metabolic pathway. In this study, G6PD enzyme was purified 1444-fold with a yield of 77% from rainbow trout liver using 2′,5′-ADP-sepharose-4B affinity chromatography. Moreover, a purity check of the enzyme was performed with sodium dodecyl sulfate–polyacrylamide gel electrophoresis. Some characteristic features like optimal pH, stable pH, optimal temperature and optimal ionic strength were determined for the purified enzyme. In addition to this, in vitro effects of ions like silver nitrate (Ag+), thallium sulphate (TI+), cobalt (II) nitrate (Co2+) and arsenic (V) oxide (As5+) on enzyme activity were researched. Half-maximal inhibitory concentration (IC50) values of Ag+, Co2+ and As5+ metal ions, which showed an inhibitory effect, were found to be 0.0044, 0.084 and 4.058 mM, respectively; and their inhibition constants ( Ki) were found to be 0.0052 ± 0.00042, 0.087 ± 0.015700 and 4.833 ± 1.753207 mM, respectively. Tl+ not exhibited inhibitory effect on the enzyme activity.

8 November 2010 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
EAEbru Akkemik
Ebru Akkemik
HBHarun Budak
Harun Budak
MCMehmet Ciftci
Mehmet Ciftci
Inhibitory effects of some drugs on glucose 6-phosphate dehydrogenase from the erythrocytes of human have been investigated. For this purpose, at the beginning, erythrocyte glucose 6-phosphate dehydrogenase was purified 2256 times in a yield of 44.22% by using ammonium sulphate precipitation and 2’, 5’-ADP Sepharose 4B affinity gel. Temperature of +4°C was maintained during the purification process. Enzyme activity was determined with the Beutler method by using a spectrophotometer at 340 nm. This method was utilized for all kinetic studies. Ketotifen, dacarbazine, thiocolchicoside, meloxicam, methotrexate, furosemide, olanzapine, methylprednizolone acetate, paricalcitol, ritodrine hydrochloride, and gadobenate-dimeglumine were used as drugs. All the drugs indicated the inhibitory effects on the enzyme. Ki constants for glucose 6-phosphate dehydrogenase were found by means of Lineweaver-Burk graphs. While methylprednizolone acetate showed competitive inhibition, the others displayed non-competitive inhibition. In addition, IC50 values of the drugs were determined by plotting Activity% vs [I].

1 March 2021 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
YCYasemin Camadan
Yasemin Camadan
BÇBaki Çiçek
Baki Çiçek
Sevki AdemSevki Adem
Sevki Adem
ÜÇÜmit Çalişir
Ümit Çalişir
EAEbru Akkemik
Ebru Akkemik
Carbonic anhydrases (CAs, EC4.2.1.1) are metalloenzymes that catalyse reversible hydration reaction of carbon dioxide to bicarbonate and protons. In recent years, there has been a great interest in inhibitors/activators of carbonic anhydrase isoenzymes. Therefore, we investigated the effects of four different carbazole Schiff base derivatives, which are believed to have a potential to be used as a drug, on human carbonic anhydrase (hCA) isoenzymes I and II under in vitro conditions. The IC50 values of carbazole Schiff base derivatives were found to be in the range of 32.09–151.2 μM for hCA isoenzyme I and 21.82–40.54 μM for hCA isoenzyme II. Among all compounds, (E)-3-(((9-Octyl-9H-carbazole-3-yl)imino)methyl)benzene-1,2-diol (C3) had the strongest inhibitory effect on hCA isoenzyme II. It was determined that 2,3,4-trimethoxy and 4-hydroxy phenyl containing carbazole compounds have selective inhibition against hCA II isoenzyme. Docking studies were performed against hCA I and II receptors using induced-fit docking method. The compounds had affinity scores varying from −7.74 ± 0.27 to −6.27 ± 0.07 kcal/mol for hCA I and from −8.04 ± 0.17 to −7.27 ± 0.18 kcal/mol for hCA II. Communicated by Ramaswamy H. Sarma

12 January 2018 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
PDF file
EAEbru Akkemik
Ebru Akkemik
BCBaki Cicek
Baki Cicek
YCYasemin Camadan
Yasemin Camadan
UCUmit Calisir
Umit Calisir
ZOZekai Onbasioglu
Zekai Onbasioglu